China has sent notifications to firms advising them against buying Nvidia’s H20 chips, notably those with any government ...

Follow along to markets on a day when the latest consumer price index will be released.

Valneva confirmed its outlook for 2025, including expectations for total revenue between 180 million and 190 million euros. Total revenue last year was approximately 170 million euros. With Pfizer, ...

Tokyo Kisen Co. Ltd. (9193.TO) Japan 1st Quarter Ended June 30 GROUP 2025 2024 Revenue Y3.42 bln Y2.86 bln Operating Profit (Y11.00 mln) (Y137.00 mln) Pretax Profit Y114.00 mln (Y13.00 mln) Net Profit ...

Japan 1st Quarter Ended June 30 GROUP 2025 2024 Revenue Y1.28 bln Y1.26 bln Operating Profit (Y128.00 mln) (Y171.00 mln) Pretax Profit (Y128.00 mln) (Y171.00 mln) Net Profit (Y153.00 mln) (Y216.00 mln ...

Japan Half-Year Ended June 30 GROUP 2025 2024 Revenue Y20.76 bln Y19.65 bln Operating Profit Y3.16 bln Y2.11 bln Pretax Profit Y3.87 bln Y2.86 bln Net Profit Y3.54 bln Y1.84 bln Per share Earnings ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Japan Half-Year Ended June 30 GROUP 2025 2024 Revenue Y142.55 bln Y136.48 bln Operating Profit Y29.77 bln Y24.01 bln Pretax Profit Y28.32 bln Y25.24 bln Net Profit Y10.72 bln Y7.72 bln Per share ...

Amita Holdings Co. Ltd. (2195.TO) Japan Half-Year Ended June 30 GROUP 2025 2024 Revenue Y2.33 bln Y2.31 bln Operating Profit Y211.00 mln Y186.00 mln Pretax Profit Y215.00 mln Y241.00 mln Net Profit ...

Japan 1st Quarter Ended June 30 GROUP 2025 Revenue Y947.00 mln Operating Profit (Y36.00 mln) Pretax Profit (Y15.00 mln) Net Profit (Y11.00 mln) Per share Earnings (Y1.82) Figures in parentheses are ...

MIRAIT Holdings Corp. (1417.TO) Japan 1st Quarter Ended June 30 GROUP 2025 2024 Revenue Y121.37 bln Y117.34 bln Operating Profit Y1.03 bln Y1.49 bln Pretax Profit Y1.30 bln Y2.49 bln Net Profit (Y1.31 ...

Schott Pharma reported an increase in revenue for its fiscal third quarter, helped by its drug-containment solutions unit and against a tough comparison base.